ShockWave Medical, Inc. (SWAV) Financials
Stock symbol SWAV is outdated, potentially delisted? Maybe it is available on other exchange?
SWAV Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| March 31, 2024 | 1.6 billion | 892.0 million |
| Dec. 31, 2023 | 1.6 billion | 897.9 million |
| Sept. 30, 2023 | 1.5 billion | 872.7 million |
| June 30, 2023 | 786.6 million | 169.7 million |
SWAV Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| March 31, 2024 | 27.5 million | 22.9 million |
| Dec. 31, 2023 | 63.6 million | 21.8 million |
| Sept. 30, 2023 | 44.1 million | 18.4 million |
| June 30, 2023 | 31.0 million | 17.0 million |
SWAV Net Income
Graph available only for paid members. Upgrade to see it.
| Date | Net Income |
|---|---|
| March 31, 2024 | 55.3 million |
| Dec. 31, 2023 | 44.3 million |
| Sept. 30, 2023 | 35.0 million |
| June 30, 2023 | 28.9 million |
SWAV Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| March 31, 2024 | 1.0 billion | 773.1 million | 44.0 million |
| Dec. 31, 2023 | 990.6 million | 731.9 million | 35.1 million |
| Sept. 30, 2023 | 917.3 million | 763.3 million | 33.9 million |
| June 30, 2023 | 258.6 million | 57.5 million | 34.8 million |
SWAV Shares Outstanding
SWAV Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| March 31, 2024 | 8.4 million | 44.5 million | 103.7 million | 74.5 million |
| Dec. 31, 2023 | 8.1 million | 42.3 million | 90.8 million | 67.2 million |
| Sept. 30, 2023 | 6.5 million | 39.5 million | 78.4 million | 56.9 million |
| June 30, 2023 | 8.7 million | 36.8 million | 86.5 million | 56.7 million |
SWAV Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| March 31, 2024 | 218.8 million | 28.2 million |
| Dec. 31, 2023 | 203.0 million | 25.3 million |
| Sept. 30, 2023 | 186.0 million | 24.5 million |
| June 30, 2023 | 180.2 million | 24.5 million |
SWAV Revenue by Segment
Graph available only for paid members. Upgrade to see it.
SWAV
Price: $334.75
52 week price:
Earnings Per Share: 3.84 USD
P/E Ratio: 36.43
Exchange: NMS
Sector: Healthcare
Industry: Medical Devices
Country: United States
Volume: 279463
Market Capitalization: 12.4 billion